Courses in Safety Sciences for Medicines

Taught by specialists from academia, industry and regulatory agencies, using real life case studies

The consortium  SafeSciMET constitutes a new and unique pan-European education and training network, developing and establishing a comprehensive Modular Education and Training Programme in Safety Sciences for Medicines funded by IMI (Innovative Medicines Initiative). IMI is a large-scale public-private partnership between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The SafeSciMET programme addresses the needs in small and large pharmaceutical companies, regulatory authorities, academic institutes and health care. The network, bringing together top institutions for drug safety education, training and research with pharmaceutical industry leaders, creates the new type, high quality and sustainable programme. In SafeSciMET there is close collaboration between 15 top institutes for drug safety education, training and research and 14 pharmaceutical companies, all members of the EFPIA (European Federation of Pharmaceutical Industries and Associations).

The tailor-made 20 courses encompass safety, ethical, regulatory and societal aspects in all phases of drug development, with emphasis on holistic, integrative, translational and 3Rs aspects of drug safety assessment. Two courses are given by teachers from the Faculty of Pharmacy, Uppsala University.

The Student Office was run by Eva Brittebo and Myron Zaluha managed the SafeSciMET website, course application and registration until 2016. The Student Office also contributed to information and communication of the SafeSciMET programme.